1. Home
  2. VCEL

VCEL

Vericel Corporation

as 02-10-2025 9:55am EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Founded: 1989 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: N/A IPO Year: 1997
Target Price: $63.29 AVG Volume (30 days): 425.1K
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.07 EPS Growth: N/A
52 Week Low/High: $39.12 - $63.00 Next Earning Date: 02-27-2025
Revenue: $226,844,000 Revenue Growth: 22.48%
Revenue Growth (this year): 23.5% Revenue Growth (next year): 21.74%

VCEL Daily Stock ML Predictions

Stock Insider Trading Activity of Vericel Corporation (VCEL)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
ZERBE ROBERT L MD VCEL Director Feb 5 '25 Sell $62.50 2,500 $156,250.00 26,595
Wotton Paul K VCEL Director Dec 4 '24 Sell $58.72 2,600 $152,672.00 27,402
Hopper Jonathan Mark VCEL Chief Medical Officer Dec 2 '24 Sell $58.72 10,000 $587,200.00 58,371
ZERBE ROBERT L MD VCEL Director Nov 22 '24 Sell $60.00 2,500 $150,000.00 26,595
Colangelo Dominick VCEL President and CEO Nov 13 '24 Sell $54.75 35,000 $1,916,250.00 220,937
MCLAUGHLIN KEVIN F VCEL Director Nov 13 '24 Sell $55.54 7,000 $388,780.00 11,900

Share on Social Networks: